Protein-protein interfaces integrated into interaction networks: Implications on drug design

Current Pharmaceutical Design

Volumn 18, Issue 30, 2012, Pages 4697-4705

  Kar, Gozde ^a   Kuzu, Guray ^a   Keskin, Ozlem ^a   Gursoy, Attila ^a  

^a KOÇ UNIVERSITY   (Turkey)

Author keywords

Drug design; Protein interaction networks; Protein protein interfaces

Indexed keywords

IMATINIB;

BINDING SITE; COMPUTER INTERFACE; DRUG DESIGN; DRUG TARGETING; HUMAN; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; REVIEW; SIGNAL TRANSDUCTION;

BINDING SITES; DRUG DESIGN; MODELS, MOLECULAR; PROTEIN BINDING; PROTEIN CONFORMATION; PROTEIN INTERACTION MAPPING; PROTEIN INTERACTION MAPS;

EID: 84866393234     PISSN: 13816128     EISSN: 18734286     Source Type: Journal    
DOI: 10.2174/138161212802651643     Document Type: Review

References (171)

1. Chene P. Drugs targeting protein-protein interactions. Chem Med Chem 2006; 1: 400-411.
2. Fry DC. Protein-protein interactions as targets for small molecule drug discovery. Biopolymers 2006; 84: 535-552.
3. Gonzalez-Ruiz D, Gohlke H. Targeting protein-protein interactions with small molecules: challenges and perspectives for computational binding epitope detection and ligand finding. Curr Med Chem 2006; 13: 2607-2625.
4. Barabasi AL, Gulbahce N, Loscalzo J. Network medicine: a network-based approach to human disease. Nat Rev Genet 2011; 12: 56-68.
5. Pujol A, Mosca R, Farres J, Aloy P. Unveiling the role of network and systems biology in drug discovery. Trends Pharmacol Sci 2010; 31: 115-123.
6. Hopkins AL. Network pharmacology: the next paradigm in drug discovery. Nat Chem Biol 2008; 4: 682-690.
7. Agoston V, Csermely P, Pongor S. Multiple weak hits confuse complex systems: a transcriptional regulatory network as an example. Phys Rev E Stat Nonlin Soft Matter Phys 2005; 71: 051909.
8. Badis G, Berger MF, Philippakis AA, et al. Diversity and complexity in DNA recognition by transcription factors. Science 2009; 324: 1720-1723.
9. Roy J, Cyert MS. Cracking the phosphatase code: docking interactions determine substrate specificity. Sci Signal 2009; 2: re9.
10. Arkin MR, Wells JA. Small-molecule inhibitors of protein-protein interactions: progressing towards the dream. Nat Rev Drug Discov 2004; 3: 301-317.
11. Grunberg R, Leckner J, Nilges M. Complementarity of structure ensembles in protein-protein binding. Structure 2004; 12: 2125-2136.
12. Lawrence MC, Colman PM. Shape complementarity at protein/protein interfaces. J Mol Biol 1993; 234: 946-950.
13. Lo Conte L, Chothia C, Janin J. The atomic structure of proteinprotein recognition sites. J Mol Biol 1999; 285: 2177-2198.
14. Sheinerman FB, Norel R, Honig B. Electrostatic aspects of proteinprotein interactions. Curr Opin Struct Biol 2000; 10: 153-159.
15. Zhang Q, Sanner M, Olson AJ. Shape complementarity of proteinprotein complexes at multiple resolutions. Proteins 2009; 75: 453-467.
16. Keskin O, Tsai CJ, Wolfson H, Nussinov R. A new, structurally nonredundant, diverse data set of protein-protein interfaces and its implications. Protein Sci 2004; 13: 1043-1055.
17. Gong S, Yoon G, Jang I, et al. PSIbase: a database of Protein Structural Interactome map (PSIMAP). Bioinformatics 2005; 21: 2541-2543.
18. Gadkari RA, Varughese D, Srinivasan N. Recognition of interaction interface residues in low-resolution structures of protein assemblies solely from the positions of C(alpha) atoms. PLoS One 2009; 4: e4476.
19. Jones S, Thornton JM. Principles of protein-protein interactions. Proc Natl Acad Sci USA 1996; 93: 13-20.
20. Jones S, Marin A, Thornton JM. Protein domain interfaces: characterization and comparison with oligomeric protein interfaces. Protein Eng 2000; 13: 77-82.
21. Jones S, Thornton JM. Analysis of protein-protein interaction sites using surface patches. J Mol Biol 1997; 272: 121-132.
22. Keskin O, Ma B, Rogale K, Gunasekaran K, Nussinov R. Proteinprotein interactions: organization, cooperativity and mapping in a bottom-up Systems Biology approach. Phys Biol 2005; 2: S24-S35.
23. Chakrabarti P, Janin J. Dissecting protein-protein recognition sites. Proteins 2002; 47: 334-343.
24. Chothia C, Janin J. Principles of protein-protein recognition. Nature 1975; 256: 705-708.
25. Keskin O, Nussinov R. Favorable scaffolds: proteins with different sequence, structure and function may associate in similar ways. Protein Eng Des Sel 2005; 18: 11-24.
26. Tsai CJ, Lin SL, Wolfson HJ, Nussinov R. Studies of proteinprotein interfaces: a statistical analysis of the hydrophobic effect. Protein Sci 1997; 6: 53-64.
27. Tsai CJ, Nussinov R. Hydrophobic folding units at protein-protein interfaces: implications to protein folding and to protein-protein association. Protein Sci 1997; 6: 1426-1437.
28. Tsai CJ, Xu D, Nussinov R. Structural motifs at protein-protein interfaces: protein cores versus two-state and three-state model complexes. Protein Sci 1997; 6: 1793-1805.
29. Negi SS, Braun W. Statistical analysis of physical-chemical properties and prediction of protein-protein interfaces. J Mol Model 2007; 13: 1157-1167.
30. Gruber J, Zawaira A, Saunders R, Barrett CP, Noble ME. Computational analyses of the surface properties of protein-protein interfaces. Acta Crystallogr D Biol Crystallogr 2007; 63: 50-57.
31. Headd JJ, Ban YE, Brown P, et al. Protein-protein interfaces: properties, preferences, and projections. J Proteome Res 2007; 6: 2576-2586.
32. Xu D, Tsai CJ, Nussinov R. Hydrogen bonds and salt bridges across protein-protein interfaces. Protein Eng 1997; 10: 999-1012.
33. De S, Krishnadev O, Srinivasan N, Rekha N. Interaction preferences across protein-protein interfaces of obligatory and nonobligatory components are different. BMC Struct Biol 2005; 5: 15.
34. Teyra J, Pisabarro MT. Characterization of interfacial solvent in protein complexes and contribution of wet spots to the interface description. Proteins 2007; 67: 1087-1095.
35. Rodier F, Bahadur RP, Chakrabarti P, Janin J. Hydration of protein-protein interfaces. Proteins 2005; 60: 36-45.
36. Kar G, Keskin O, Gursoy A, Nussinov R. Allostery and population shift in drug discovery. Curr Opin Pharmacol 2010; 10: 715-722.
37. Ozbabacan SE, Engin HB, Gursoy A, Keskin O. Transient proteinprotein interactions. Protein Eng Des Sel 2011; 24: 635-648.
38. Guharoy M, Chakrabarti P. Secondary structure based analysis and classification of biological interfaces: identification of binding motifs in protein-protein interactions. Bioinformatics 2007; 23: 1909-1918.
39. Mintseris J, Weng Z. Structure, function, and evolution of transient and obligate protein-protein interactions. Proc Natl Acad Sci USA 2005; 102: 10930-10935.
40. Ofran Y, Rost B. Analysing six types of protein-protein interfaces. J Mol Biol 2003; 325: 377-387.
41. Vacic V, Uversky VN, Dunker AK, Lonardi S. Composition Profiler: a tool for discovery and visualization of amino acid composition differences. BMC Bioinformatics 2007; 8: 211.
42. Zhanhua C, Gan JG, Lei L, Sakharkar MK, Kangueane P. Protein subunit interfaces: heterodimers versus homodimers. Bioinformation 2005; 1: 28-39.
43. Tuncbag N, Gursoy A, Guney E, Nussinov R, Keskin O. Architectures and functional coverage of protein-protein interfaces. J Mol Biol 2008; 381: 785-802.
44. Haliloglu T, Keskin O, Ma B, Nussinov R. How similar are protein folding and protein binding nuclei? Examination of vibrational motions of energy hot spots and conserved residues. Biophys J 2005; 88: 1552-1559.
45. Keskin O, Nussinov R. Similar binding sites and different partners: implications to shared proteins in cellular pathways. Structure 2007; 15: 341-354.
46. Veselovsky AV, Ivanov YD, Ivanov AS, et al. Protein-protein interactions: mechanisms and modification by drugs. J Mol Recognit 2002; 15: 405-422.
47. Tsuchiya Y, Nakamura H, Kinoshita K. Discrimination between biological interfaces and crystal-packing contacts. Advances and Applications in Bioinformatics and Chemistry 2008; 2008: 99-113.
48. Kuhn D, Weskamp N, Schmitt S, Hullermeier E, Klebe G. From the similarity analysis of protein cavities to the functional classification of protein families using cavbase. J Mol Biol 2006; 359: 1023-1044.
49. Binkowski TA, Naghibzadeh S, Liang J. CASTp: Computed Atlas of Surface Topography of proteins. Nucleic Acids Res 2003; 31: 3352-3355.
50. Dundas J, Ouyang Z, Tseng J, et al. CASTp: computed atlas of surface topography of proteins with structural and topographical mapping of functionally annotated residues. Nucleic Acids Res 2006; 34: W116-W118.
51. An J, Totrov M, Abagyan R. Pocketome via comprehensive identification and classification of ligand binding envelopes. Mol Cell Proteomics 2005; 4: 752-761.
52. Li X, Keskin O, Ma B, Nussinov R, Liang J. Protein-protein interactions: hot spots and structurally conserved residues often locate in complemented pockets that pre-organized in the unbound states: implications for docking. J Mol Biol 2004; 344: 781-795.
53. Veselovsky AV, Archakov AI. Inhibitors of protein-protien interactions as potential drugs. Curr Comput Aided Drug Des 2007; 3: 51-58.
54. Arkin M. Protein-protein interactions and cancer: small molecules going in for the kill. Curr Opin Chem Biol 2005; 9: 317-324.
55. Lipinski CA, Lombardo F, Dominy BW, Feeney PJ. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Deliv Rev 2001; 46: 3-26.
56. Walters WP, Ajay, Murcko MA. Recognizing molecules with druglike properties. Curr Opin Chem Biol 1999; 3: 384-387.
57. Bradford JR, Needham CJ, Bulpitt AJ, Westhead DR. Insights into protein-protein interfaces using a Bayesian network prediction method. J Mol Biol 2006; 362: 365-386.
58. Larsen TA, Olson AJ, Goodsell DS. Morphology of protein-protein interfaces. Structure 1998; 6: 421-427.
59. Nguyen MN, Rajapakse JC, Duan K. Amino acid features for prediction of protein-protein interface residues with support vector machines. Proceedings of EvoBIO 2007; 2007: 187-196.
60. Zhanhua C, Gan JG, Lei L, et al. Identification of critical heterodimer protein interface parameters by multi-dimensional scaling in euclidian space. Front Biosci 2005; 10: 844-852.
61. von Eichborn J, Gunther S, Preissner R. Structural features and evolution of protein-protein interactions. Genome Inform 2010; 22: 1-10.
62. Baussand J, Camproux AC. Deciphering the shape and deformation of secondary structures through local conformation analysis. BMC Struct Biol 2011; 11: 9.
63. Neuvirth H, Raz R, Schreiber G. ProMate: a structure based prediction program to identify the location of protein-protein binding sites. J Mol Biol 2004; 338: 181-199.
64. Horton N, Lewis M. Calculation of the free energy of association for protein complexes. Protein Sci 1992; 1: 169-181.
65. Tuncbag N, Kar G, Keskin O, Gursoy A, Nussinov R. A survey of available tools and web servers for analysis of protein-protein interactions and interfaces. Brief Bioinform 2009; 10: 217-232.
66. Henrick K, Thornton JM. PQS: a protein quaternary structure file server. Trends Biochem Sci 1998; 23: 358-361.
67. Janin J. Specific versus non-specific contacts in protein crystals. Nat Struct Biol 1997; 4: 973-974.
68. Wodak SJ, Mendez R. Prediction of protein-protein interactions: the CAPRI experiment, its evaluation and implications. Curr Opin Struct Biol 2004; 14: 242-249.
69. Norel R, Petrey D, Wolfson HJ, Nussinov R. Examination of shape complementarity in docking of unbound proteins. Proteins 1999; 36: 307-317.
70. Gray JJ, Moughon S, Wang C, et al. Protein-protein docking with simultaneous optimization of rigid-body displacement and sidechain conformations. J Mol Biol 2003; 331: 281-299.
71. Cheng AC, Coleman RG, Smyth KT, et al. Structure-based maximal affinity model predicts small-molecule druggability. Nat Biotechnol 2007; 25: 71-75.
72. Smith RD, Hu L, Falkner JA, et al. Exploring protein-ligand recognition with Binding MOAD. J Mol Graph Model 2006; 24: 414-425.
73. Valdar WS, Thornton JM. Conservation helps to identify biologically relevant crystal contacts. J Mol Biol 2001; 313: 399-416.
74. Zhu H, Domingues FS, Sommer I, Lengauer T. NOXclass: prediction of protein-protein interaction types. BMC Bioinformatics 2006; 7: 27.
75. Bernauer J, Bahadur RP, Rodier F, Janin J, Poupon A. DiMoVo: a Voronoi tessellation-based method for discriminating crystallographic and biological protein-protein interactions. Bioinformatics 2008; 24: 652-658.
76. Liu S, Li Q, Lai L. A combinatorial score to distinguish biological and nonbiological protein-protein interfaces. Proteins 2006; 64: 68-78.
77. Liu Q, Li J. Propensity vectors of low-ASA residue pairs in the distinction of protein interactions. Proteins 2010; 78: 589-602.
78. Shakhnovich BE, Dokholyan NV, DeLisi C, Shakhnovich EI. Functional fingerprints of folds: evidence for correlated structurefunction evolution. J Mol Biol 2003; 326: 1-9.
79. Torrance JW, Bartlett GJ, Porter CT, Thornton JM. Using a library of structural templates to recognise catalytic sites and explore their evolution in homologous families. J Mol Biol 2005; 347: 565-581.
80. Caffrey DR, Somaroo S, Hughes JD, Mintseris J, Huang ES. Are protein-protein interfaces more conserved in sequence than the rest of the protein surface? Protein Sci 2004; 13: 190-202.
81. Thorn KS, Bogan AA. ASEdb: a database of alanine mutations and their effects on the free energy of binding in protein interactions. Bioinformatics 2001; 17: 284-285.
82. Pupko T, Bell RE, Mayrose I, Glaser F, Ben-Tal N. Rate4Site: an algorithmic tool for the identification of functional regions in proteins by surface mapping of evolutionary determinants within their homologues. Bioinformatics 2002; 18 Suppl 1: S71-S77.
83. Grishin NV, Phillips MA. The subunit interfaces of oligomeric enzymes are conserved to a similar extent to the overall protein sequences. Protein Sci 1994; 3: 2455-2458.
84. Ouzounis C, Perez-Irratxeta C, Sander C, Valencia A. Are binding residues conserved? Pac Symp Biocomput 1998; 401-412.
85. Bartlett GJ, Porter CT, Borkakoti N, Thornton JM. Analysis of catalytic residues in enzyme active sites. J Mol Biol 2002; 324: 105-121.
86. Ma B, Elkayam T, Wolfson H, Nussinov R. Protein-protein interactions: structurally conserved residues distinguish between binding sites and exposed protein surfaces. Proc Natl Acad Sci USA 2003; 100: 5772-5777.
87. Konc J, Janezic D. Protein-protein binding-sites prediction by protein surface structure conservation. J Chem Inf Model 2007; 47: 940-944.
88. Watson JD, Laskowski RA, Thornton JM. Predicting protein function from sequence and structural data. Curr Opin Struct Biol 2005; 15: 275-284.
89. Wang B, Ge LS, Huang D, Wong HS. Prediction of protein-protein interacting sites by combining SVM algorithm with Bayesian method. ICNC 2007 2007; 2: 329-333.
90. Laskowski RA, Watson JD, Thornton JM. Protein function prediction using local 3D templates. J Mol Biol 2005; 351: 614-626.
91. Laskowski RA, Watson JD, Thornton JM. ProFunc: a server for predicting protein function from 3D structure. Nucleic Acids Res 2005; 33: W89-W93.
92. Kortemme T, Baker D. A simple physical model for binding energy hot spots in protein-protein complexes. Proc Natl Acad Sci USA 2002; 99: 14116-14121.
93. Chung JL, Wang W, Bourne PE. Exploiting sequence and structure homologs to identify protein-protein binding sites. Proteins 2006; 62: 630-640.
94. Keskin O, Ma B, Nussinov R. Hot regions in protein-protein interactions: the organization and contribution of structurally conserved hot spot residues. J Mol Biol 2005; 345: 1281-1294.
95. Illergard K, Ardell DH, Elofsson A. Structure is three to ten times more conserved than sequence--a study of structural response in protein cores. Proteins 2009; 77: 499-508.
96. Valas RE, Yang S, Bourne PE. Nothing about protein structure classification makes sense except in the light of evolution. Curr Opin Struct Biol 2009; 19: 329-334.
97. Zhang QC, Petrey D, Norel R, Honig BH. Protein interface conservation across structure space. Proc Natl Acad Sci USA 2010; 107: 10896-10901.
98. Tsai CJ, Lin SL, Wolfson HJ, Nussinov R. A dataset of proteinprotein interfaces generated with a sequence-order-independent comparison technique. J Mol Biol 1996; 260: 604-620.
99. Marchler-Bauer A, Anderson JB, DeWeese-Scott C, et al. CDD: a curated Entrez database of conserved domain alignments. Nucleic Acids Res 2003; 31: 383-387.
100. Marchler-Bauer A, Panchenko AR, Shoemaker BA, et al. CDD: a database of conserved domain alignments with links to domain three-dimensional structure. Nucleic Acids Res 2002; 30: 281-283.
101. Kim WK, Henschel A, Winter C, Schroeder M. The many faces of protein-protein interactions: A compendium of interface geometry. PLoS Comput Biol 2006; 2: e124.
102. Korkin D, Davis FP, Sali A. Localization of protein-binding sites within families of proteins. Protein Sci 2005; 14: 2350-2360.
103. Stein A, Ceol A, Aloy P. 3did: identification and classification of domain-based interactions of known three-dimensional structure. Nucleic Acids Res 2011; 39: D718-D723.
104. Aung Z, Tan SH, Ng SK, Tan KL. PPiClust: efficient clustering of 3D protein-protein interaction interfaces. J Bioinform Comput Biol 2008; 6: 415-433.
105. Gao M, Skolnick J. Structural space of protein-protein interfaces is degenerate, close to complete, and highly connected. Proc Natl Acad Sci USA 2010; 107: 22517-22522.
106. Keskin O, Gursoy A, Ma B, Nussinov R. Principles of proteinprotein interactions: what are the preferred ways for proteins to interact? Chem Rev 2008; 108: 1225-1244.
107. Martin J. Beauty is in the eye of the beholder: proteins can recognize binding sites of homologous proteins in more than one way. PLoS Comput Biol 2010; 6: e1000821.
108. Clackson T, Wells JA. A hot spot of binding energy in a hormonereceptor interface. Science 1995; 267: 383-386.
109. Bogan AA, Thorn KS. Anatomy of hot spots in protein interfaces. J Mol Biol 1998; 280: 1-9.
110. Shulman-Peleg A, Shatsky M, Nussinov R, Wolfson HJ. Spatial chemical conservation of hot spot interactions in protein-protein complexes. BMC Biol 2007; 5: 43.
111. Aytuna AS, Gursoy A, Keskin O. Prediction of protein-protein interactions by combining structure and sequence conservation in protein interfaces. Bioinformatics 2005; 21: 2850-2855.
112. Moreira IS, Fernandes PA, Ramos MJ. Hot spots--a review of the protein-protein interface determinant amino-acid residues. Proteins 2007; 68: 803-812.
113. Hu Z, Ma B, Wolfson H, Nussinov R. Conservation of polar residues as hot spots at protein interfaces. Proteins 2000; 39: 331-342.
114. Ahmad S, Keskin O, Mizuguchi K, Sarai A, Nussinov R. CCRXP: exploring clusters of conserved residues in protein structures. Nucleic Acids Res 2010; 38: W398-W401.
115. Halperin I, Wolfson H, Nussinov R. Protein-protein interactions; coupling of structurally conserved residues and of hot spots across interfaces. Implications for docking. Structure 2004; 12: 1027-1038.
116. Gao Y, Wang R, Lai L. Structure-based method for analyzing protein-protein interfaces. J Mol Model 2004; 10: 44-54.
117. Guerois R, Nielsen JE, Serrano L. Predicting changes in the stability of proteins and protein complexes: a study of more than 1000 mutations. J Mol Biol 2002; 320: 369-387.
118. Huo S, Massova I, Kollman PA. Computational alanine scanning of the 1:1 human growth hormone-receptor complex. J Comput Chem 2002; 23: 15-27.
119. Rajamani D, Thiel S, Vajda S, Camacho CJ. Anchor residues in protein-protein interactions. Proc Natl Acad Sci USA 2004; 101: 11287-11292.
120. Moreira IS, Fernandes PA, Ramos MJ. Hot spot occlusion from bulk water: a comprehensive study of the complex between the lysozyme HEL and the antibody FVD1.3. J Phys Chem B 2007; 111: 2697-2706.
121. Guney E, Tuncbag N, Keskin O, Gursoy A. HotSprint: database of computational hot spots in protein interfaces. Nucleic Acids Res 2008; 36: D662-D666.
122. Ofran Y, Rost B. Protein-protein interaction hotspots carved into sequences. PLoS Comput Biol 2007; 3: e119.
123. Acuner Ozbabacan SE, Gursoy A, Keskin O, Nussinov R. Conformational ensembles, signal transduction and residue hot spots: application to drug discovery. Curr Opin Drug Discov Devel 2010; 13: 527-537.
124. Brenke R, Kozakov D, Chuang GY, et al. Fragment-based identification of druggable 'hot spots' of proteins using Fourier domain correlation techniques. Bioinformatics 2009; 25: 621-627.
125. Ma B, Nussinov R. Trp/Met/Phe hot spots in protein-protein interactions: potential targets in drug design. Curr Top Med Chem 2007; 7: 999-1005.
126. Ma B, Pan Y, Gunasekaran K, et al. The contribution of the Trp/Met/Phe residues to physical interactions of p53 with cellular proteins. Phys Biol 2005; 2: S56-S66.
127. Wells JA, McClendon CL. Reaching for high-hanging fruit in drug discovery at protein-protein interfaces. Nature 2007; 450: 1001-1009.
128. Ideker T, Sharan R. Protein networks in disease. Genome Res 2008; 18: 644-652.
129. Kann MG. Protein interactions and disease: computational approaches to uncover the etiology of diseases. Brief Bioinform 2007; 8: 333-346.
130. Wachi S, Yoneda K, Wu R. Interactome-transcriptome analysis reveals the high centrality of genes differentially expressed in lung cancer tissues. Bioinformatics 2005; 21: 4205-4208.
131. Jonsson PF, Bates PA. Global topological features of cancer proteins in the human interactome. Bioinformatics 2006; 22: 2291-2297.
132. Lim J, Hao T, Shaw C, et al. A protein-protein interaction network for human inherited ataxias and disorders of Purkinje cell degeneration. Cell 2006; 125: 801-814.
133. Amberger J, Bocchini CA, Scott AF, Hamosh A. McKusick's Online Mendelian Inheritance in Man (OMIM). Nucleic Acids Res 2009; 37: D793-D796.
134. Xu J, Li Y. Discovering disease-genes by topological features in human protein-protein interaction network. Bioinformatics 2006; 22: 2800-2805.
135. Goh KI, Cusick ME, Valle D, et al. The human disease network. Proc Natl Acad Sci USA 2007; 104: 8685-8690.
136. Kitano H. Biological robustness. Nat Rev Genet 2004; 5: 826-837.
137. Hase T, Tanaka H, Suzuki Y, Nakagawa S, Kitano H. Structure of protein interaction networks and their implications on drug design. PLoS Comput Biol 2009; 5: e1000550.
138. Zhu M, Gao L, Li X, et al. The analysis of the drug-targets based on the topological properties in the human protein-protein interaction network. J Drug Target 2009; 17: 524-532.
139. Xenarios I, Salwinski L, Duan XJ, et al. DIP, the Database of Interacting Proteins: a research tool for studying cellular networks of protein interactions. Nucleic Acids Res 2002; 30: 303-305.
140. Isserlin R, El-Badrawi RA, Badery GD. The Biomolecular Interaction Network Database in PSI-MI 2.5. Database. The Journal of Biological Databases and Curation 2011.
141. Stark C, Breitkreutz BJ, Reguly T, et al. BioGRID: a general repository for interaction datasets. Nucleic Acids Res 2006; 34: D535-D539.
142. Hermjakob H, Montecchi-Palazzi L, Lewington C, et al. IntAct: an open source molecular interaction database. Nucleic Acids Res 2004; 32: D452-D455.
143. Peri S, Navarro JD, Kristiansen TZ, et al. Human protein reference database as a discovery resource for proteomics. Nucleic Acids Res 2004; 32: D497-D501.
144. Schoof H, Spannagl M, Yang L, et al. Munich information center for protein sequences plant genome resources: a framework for integrative and comparative analyses 1(W). Plant Physiol 2005; 138: 1301-1309.
145. Han K, Park B, Kim H, Hong J, Park J. HPID: the Human Protein Interaction Database. Bioinformatics 2004; 20: 2466-2470.
146. Gong S, Yoon G, Jang I, et al. PSIbase: a database of Protein Structural Interactome map (PSIMAP). Bioinformatics 2005; 21: 2541-2543.
147. Raghavachari B, Tasneem A, Przytycka TM, Jothi R. DOMINE: a database of protein domain interactions. Nucleic Acids Res 2008; 36: D656-D661.
148. Aloy P, Russell RB. Interrogating protein interaction networks through structural biology. Proc Natl Acad Sci USA 2002; 99: 5896-5901.
149. Dawelbait G, Winter C, Zhang Y, et al. Structural templates predict novel protein interactions and targets from pancreas tumour gene expression data. Bioinformatics 2007; 23: i115-i124.
150. Huang YJ, Hang D, Lu LJ, et al. Targeting the human cancer pathway protein interaction network by structural genomics. Mol Cell Proteomics 2008; 7: 2048-2060.
151. Kar G, Gursoy A, Keskin O. Human cancer protein-protein interaction network: a structural perspective. PLoS Comput Biol 2009; 5: e1000601.
152. Tuncbag N, Gursoy A, Nussinov R, Keskin O. Predicting proteinprotein interactions on a proteome scale by matching evolutionary and structural similarities at interfaces using PRISM. Nat Protoc 2011; 6: 1341-1354.
153. Gursoy A, Keskin O, Nussinov R. Topological properties of protein interaction networks from a structural perspective. Biochem Soc Trans 2008; 36: 1398-1403.
154. Tuncbag N, Kar G, Gursoy A, Keskin O, Nussinov R. Towards inferring time dimensionality in protein-protein interaction networks by integrating structures: the p53 example. Mol Biosyst 2009; 5: 1770-1778.
155. Keskin O, Gursoy A, Ma B, Nussinov R. Towards drugs targeting multiple proteins in a systems biology approach. Curr Top Med Chem 2007; 7: 943-951.
156. Sugaya N, Ikeda K, Tashiro T, et al. An integrative in silico approach for discovering candidates for drug-targetable proteinprotein interactions in interactome data. BMC Pharmacol 2007; 7: 10.
157. Aloy P, Bottcher B, Ceulemans H, et al. Structure-based assembly of protein complexes in yeast. Science 2004; 303: 2026-2029.
158. Xie L, Bourne PE. Structure-based systems biology for analyzing off-target binding. Curr Opin Struct Biol 2011; 21: 189-199.
159. Chong CR, Sullivan DJ, Jr. New uses for old drugs. Nature 2007; 448: 645-646.
160. DiMasi JA, Hansen RW, Grabowski HG. The price of innovation: new estimates of drug development costs. J Health Econ 2003; 22: 151-185.
161. Kinnings SL, Liu N, Buchmeier N, et al. Drug discovery using chemical systems biology: repositioning the safe medicine Comtan to treat multi-drug and extensively drug resistant tuberculosis. PLoS Comput Biol 2009; 5: e1000423.
162. Weber A, Casini A, Heine A, et al. Unexpected nanomolar inhibition of carbonic anhydrase by COX-2-selective celecoxib: new pharmacological opportunities due to related binding site recognition. J Med Chem 2004; 47: 550-557.
163. Frantz S. Drug discovery: playing dirty. Nature 2005; 437: 942-943.
164. Paolini GV, Shapland RH, van Hoorn WP, Mason JS, Hopkins AL. Global mapping of pharmacological space. Nat Biotechnol 2006; 24: 805-815.
165. Lee SJ, Wang JY. Exploiting the promiscuity of imatinib. J Biol 2009; 8: 30.
166. Druker BJ. Translation of the Philadelphia chromosome into therapy for CML. Blood 2008; 112: 4808-4817.
167. Winger JA, Hantschel O, Superti-Furga G, Kuriyan J. The structure of the leukemia drug imatinib bound to human quinone reductase 2 (NQO2). BMC Struct Biol 2009; 9: 7.
168. Nagar B, Bornmann WG, Pellicena P, et al. Crystal structures of the kinase domain of c-Abl in complex with the small molecule inhibitors PD173955 and imatinib (STI-571). Cancer Res 2002; 62: 4236-4243.
169. Kanehisa M. The KEGG database. Novartis Found Symp 2002; 247: 91-101; discussion -3, 19-28, 244-252.
170. Xie L, Bourne PE. Functional coverage of the human genome by existing structures, structural genomics targets, and homology models. PLoS Comput Biol 2005; 1: e31.
171. Tuncbag N, Keskin O, Gursoy A. HotPoint: hot spot prediction server for protein interfaces. Nucleic Acids Res 2010; 38: W402-W406.